Aditya Anand

Dr. Aditya Anand

Department of Internal Medicine, University of South Florida, Tampa, Florida, USA
+2
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MCManjunatha Chandana
Manjunatha Chandana
AAAditya Anand
Aditya Anand
SGSourav Ghosh
Sourav Ghosh
RDRahul Das
Rahul Das
SBSubhashree Beura
Subhashree Beura
VNViswanathan Arun Nagaraj
Viswanathan Arun Nagaraj
Heme-biosynthetic pathway of malaria parasite is dispensable for asexual stages, but essential for mosquito and liver stages. Despite having backup mechanisms to acquire hemoglobin-heme, pathway intermediates and/or enzymes from the host, asexual parasites express heme pathway enzymes and synthesize heme. Here we show heme synthesized in asexual stages promotes cerebral pathogenesis by enhancing hemozoin formation. Hemozoin is a parasite molecule associated with inflammation, aberrant host-immune responses, disease severity and cerebral pathogenesis. The heme pathway knockout parasites synthesize less hemozoin, and mice infected with knockout parasites are protected from cerebral malaria and death due to anemia is delayed. Biosynthetic heme regulates food vacuole integrity and the food vacuoles from knockout parasites are compromised in pH, lipid unsaturation and proteins, essential for hemozoin formation. Targeting parasite heme synthesis by griseofulvin—a FDA-approved antifungal drug, prevents cerebral malaria in mice and provides an adjunct therapeutic option for cerebral and severe malaria.

1 February 2016 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SRSuvasmita Rath
Suvasmita Rath
AAAditya Anand
Aditya Anand
NGNilabh Ghosh
Nilabh Ghosh
LDLopamudra Das
Lopamudra Das
SKShrikant B. Kokate
Shrikant B. Kokate
ABAsima Bhattacharyya
Asima Bhattacharyya

14 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
SGSourav Ghosh
Sourav Ghosh
RKRajib Kundu
Rajib Kundu
MCManjunatha Chandana
Manjunatha Chandana
RDRahul Das
Rahul Das
AAAditya Anand
Aditya Anand
VNViswanathan Arun Nagaraj
Viswanathan Arun Nagaraj
Malaria parasite lacks canonical pathways for amino acid biosynthesis and depends primarily on hemoglobin degradation and extracellular resources for amino acids. Interestingly, a putative gene for glutamine synthetase (GS) is retained despite glutamine being an abundant amino acid in human and mosquito hosts. Here we show Plasmodium GS has evolved as a unique type I enzyme with distinct structural and regulatory properties to adapt to the asexual niche. Methionine sulfoximine (MSO) and phosphinothricin (PPT) inhibit parasite GS activity. GS is localized to the parasite cytosol and abundantly expressed in all the life cycle stages. Parasite GS displays species-specific requirement in Plasmodium falciparum (Pf) having asparagine-rich proteome. Targeting PfGS affects asparagine levels and inhibits protein synthesis through eIF2α phosphorylation leading to parasite death. Exposure of artemisinin-resistant Pf parasites to MSO and PPT inhibits the emergence of viable parasites upon artemisinin treatment.

27 September 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PVPradeep Mini Vaishalli
Pradeep Mini Vaishalli
RDRahul Das
Rahul Das
HCHarveer Singh Cheema
Harveer Singh Cheema
SGSourav Ghosh
Sourav Ghosh
MCManjunatha Chandana
Manjunatha Chandana
VNViswanathan Arun Nagaraj
Viswanathan Arun Nagaraj
High mobility group box (HMGB) proteins belong to the high mobility group (HMG) superfamily of non-histone nuclear proteins that are involved in chromatin remodeling, regulation of gene expression, and DNA repair. When extracellular, HMGBs serve as alarmins inducing inflammation, and this is attributed to the proinflammatory activity of box B. Here, we show that Plasmodium HMGB1 has key amino acid changes in box B resulting in the loss of TNF-a stimulatory activity. Sitedirected mutagenesis of the critical amino acids in box B with respect to mouse HMGB1 renders recombinant Plasmodium berghei (Pb) HMGB1 capable of inducing TNF-a release. Targeted deletion of PbHMGB1 and a detailed in vivo phenotyping show that PbHMGB1 knockout (KO) parasites can undergo asexual stage development. Interestingly, Balb/c mice-infected with PbHMGB1KO parasites display a protective phenotype with subsequent clearance of blood parasitemia and develop long-lasting protective immunity against the challenges performed with Pb wildtype parasites. The characterization of splenic responses shows prominent germinal centers leading to effective humoral responses and enhanced T follicular helper cells. There is also complete protection from experimental cerebral malaria in CBA/CaJ mice susceptible to cerebral pathogenesis with subsequent parasite clearance. Transcriptomic studies suggest the involvement of PbHMGB1 in pir expression. Our findings highlight the gene regulatory function of parasite HMGB1 and its in vivo significance in modulating the host immune responses. Further, clearance of asexual stages in PbHMGB1KO-infected mice underscores the important role of parasite HMGB1 in host immune evasion. These findings have implications in developing attenuated bloodstage vaccines for malaria.

13 April 2023 in Microbiology Spectrum
Verified
Journal Article
Open access
AAAditya Anand
Aditya Anand
MCManjunatha Chandana
Manjunatha Chandana
SGSourav Ghosh
Sourav Ghosh
RDRahul Das
Rahul Das
NSNalini Singh
Nalini Singh
VNViswanathan Arun Nagaraj
Viswanathan Arun Nagaraj
Food vacuoles of the malaria parasite are involved in the degradation of red blood cell hemoglobin. The amino acids derived from hemoglobin degradation support parasite growth, and the heme released is detoxified into hemozoin.

6 May 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
ASAhmad Rushdi Shakri
Ahmad Rushdi Shakri
AMAlok Das Mohapatra
Alok Das Mohapatra
Jhasketan BadhaiJhasketan Badhai
Jhasketan Badhai
AAAditya Anand
Aditya Anand
AVAlvin Varghese
Alvin Varghese
DRDipak Kumar KUMAR RAJ
Dipak Kumar KUMAR RAJ
Background/Objectives: Malaria affects almost half of the world’s population and causes more than 600,000 deaths annually. Young children in malaria-endemic areas have the highest mortality rate because of their immature immune systems. Global efforts to control the disease have had limited success, with two WHO-recommended pre-erythrocytic malaria vaccines showing suboptimal efficacy; no vaccine has yet been approved against the blood stages of the parasite that causes the clinical symptoms of malaria. Therefore, there is an urgent need to identify new vaccine candidates against the parasite’s blood stages to achieve protection against the disease. Methods: Previous studies in our lab identified a few potential vaccine candidates expressed on the surface of malaria-parasite-infected RBCs using sera from disease-resistant children from malaria-endemic regions and a phage-displayed cDNA library generated from P. falciparum. In an innovative approach, we successfully immunized mice using live Plasmodium falciparum-infected red blood cells {Pf-iRBCs (L)}, the membrane fraction of P. falciparum-infected RBCs {Pf-iRBCs (M)}, and live uninfected human red blood cells (hRBCs) in suitable adjuvants. The polyclonal sera produced against Pf-iRBC immunizations were evaluated for specificity and parasite inhibition in vitro and used in a phage display biopanning assay to identify novel antigens on the surface of Pf-iRBCs. Results: Our data indicate that the polyclonal serum produced in BALB/cJ mice, against live Pf-iRBC (L) and their membrane fraction, specifically interacts with surface antigens of parasitic origin on Pf-iRBCs. Additionally, the anti-Pf-iRBC polyclonal serum exhibits significant parasite-killing activity in the in vitro growth inhibition assay (GIA). We have identified both known and novel antigens associated with the Pf-iRBC membrane using phage display cDNA library screening assays. Conclusions: As a proof of concept, our phage display screening identified antigens known to be associated with the Pf-iRBC membrane. Additionally, we identified several unknown Pf-iRBC antigens predicted to be associated with Pf-iRBC membrane (PlasmoDB), suggesting that our approach has the potential to identify novel antigens yet to be evaluated as vaccine candidates against falciparum malaria. In our follow-on studies, we will evaluate the newly identified antigen using an integrated in vitro and in vivo challenge experiment. These studies form the core supporting data for further evaluation of the vaccine potential of novel Pf-iRBC antigens and for follow-on vaccine trials in non-human primates, with an ultimate goal of a malaria vaccine for humans.